Analytical Data
-
基因名
SVTLE
- Application
-
别名
SVTLE;
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
F8S114
-
表达区间
25-262aa
-
氨基酸序列
VIGGDECNINEHRFLVALYDYWSQSFLCGGTLINEEWVLTAKHCDRTHILIYVGVHDRSVQFDKEQRRFPKEKYFFDCSNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRAMGWGQTTSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGLYTKVFDHLDWIQSIIAGEKTVNCPP
-
分子量
42.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SVTLE (Serratia marcescens virulence factor that regulates the expression of type III secretion system) is a protein that has garnered significant attention in the field of microbiology and infectious disease research. The study of SVTLE is primarily contextualized within the pathogenic mechanisms of Serratia marcescens, a Gram-negative bacterium known for its role in nosocomial infections. SVTLE is believed to play a critical role in the bacterium's virulence by modulating the expression of its type III secretion system (T3SS), a needle-like structure that allows the bacterium to inject effector proteins into host cells, subverting host immune responses. The growing prevalence of antibiotic-resistant strains of Serratia marcescens and the limited therapeutic options available underscore the urgency of understanding the molecular underpinnings of its pathogenicity. Research on SVTLE not only aims to elucidate the specific regulatory mechanisms governing T3SS expression but also seeks to identify potential therapeutic targets to mitigate the effects of infections caused by this opportunistic pathogen. Discoveries in this area could pave the way for novel treatments and strategies to combat Serratia marcescens infections, particularly in vulnerable patient populations such as those in intensive care units. Consequently, the study of SVTLE serves as a critical intersection of microbiology, pathogenesis, and therapeutic development, highlighting the importance of basic research in addressing pressing clinical challenges in infectious diseases.












